In contrast, the responder rate and single or polyfunctionality quantitation for CD8+ T cells was comparable between the cohorts, although CLL vaccinees showed a trend toward lower IFNγ production. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.